Tien‐Yu Huang

487 citations
14 papers · 274 indexed · h-index 9
Topics
Liver Disease Diagnosis and Treatment (4 papers)Drug-Induced Hepatotoxicity and Protection (2 papers)MicroRNA in disease regulation (2 papers)
Partner nations
TaiwanUnited States

In The Last Decade

Tien‐Yu Huang

13 papers receiving 270 citations

Peers

Tien‐Yu Huang
Comparison fields: 5 of 60
  • Endocrinology, Diabetes and Metabolism 65
  • Molecular Biology 62
  • Oncology 53
  • Epidemiology 53
  • Pulmonary and Respiratory Medicine 46
Replace Shih-Horng Huang with:
Shih-Horng Huang Taiwan
Li Xiao China
Lise Van Wyngene Belgium
Lin Guan China
Lu Zhong China
Nirmeen Megahed Egypt
Woo-Kyu Jeon South Korea
Clare A. Balendran Sweden
Biswabandhu Bankura India
Tien‐Yu Huang relative to Shih-Horng Huang Taiwan Shih-Horng Huang's profile →
Citations per field
00.5×3.5×
Shih-Horng Huang · 1×
Citations per year

Countries citing papers authored by Tien‐Yu Huang

Since Specialization
Citations

This map shows the geographic impact of Tien‐Yu Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tien‐Yu Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tien‐Yu Huang more than expected).

Fields of papers citing papers by Tien‐Yu Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tien‐Yu Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tien‐Yu Huang. The network helps show where Tien‐Yu Huang may publish in the future.

Co-authorship network of co-authors of Tien‐Yu Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Tien‐Yu Huang. A scholar is included among the top collaborators of Tien‐Yu Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tien‐Yu Huang. Tien‐Yu Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 1
2 0
3 12
4 7
5 2
6 9
7 1
8 8
9 17
10 16
11 83
12 12
13 54
14 52

About Tien‐Yu Huang

Tien‐Yu Huang is a scholar working on Otorhinolaryngology, Toxicology and Hepatology, having authored 14 papers that have together received 274 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (65 citations), Hepatology (30 citations) and Pharmacology (30 citations). Tien‐Yu Huang has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Mengting Wang, Chang‐Hsun Hsieh, Heng-Cheng Chu, Wan‐Ju Lee, Ching‐Len Liao, Tsai‐Yuan Hsieh, Yi‐Ling Lin, You‐Chen Chao, Wei‐Kuo Chang and Yu‐Lueng Shih. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026